BRIEF: Rimag Group secures CSRC approval for full circulation of H-Shares
Medical imaging services provider Jiangxi Rimag Group Co. Ltd. (2522.HK) announced on Wednesday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 51.562 million of its…
Medical imaging group Rimag sets growth focus with IPO
Buoyed by a healthcare boom, the provider of medical imaging services has filed to list on the Hong Kong Stock Exchange. Key Takeaways: Revenues have been rising at Rimag Group,…
RELATED ARTICLES
-
BRIEF: Qyuns Therapeutics secures CSRC approval for full H-share circulation
2509.HK
- BRIEF: Green Tea Group secures CSRC approval for Hong Kong IPO
- BRIEF: Coland Ocean secures CSRC approval for Hong Kong IPO
-
BRIEF: Surging Laopu Gold to boost share float after full circulation approval
6181.HK
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
